Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Original language | English (US) |
---|---|
Pages (from-to) | 425-430 |
Number of pages | 6 |
Journal | Nature |
Volume | 343 |
Issue number | 6257 |
DOIs | |
State | Published - 1990 |
ASJC Scopus subject areas
- General